{"filing":{"accession_number":"0001628280-26-051845","cik":"0000910329","ticker":"MED","company_name":"MEDIFAST INC","form":"8-K","filing_date":"2026-08-03","report_date":"2026-08-03","primary_document":"med-20260803.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/910329/000162828026051845/med-20260803.htm"},"events":[{"id":23440,"run_id":21191,"accession_number":"0001628280-26-051845","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Medifast issued a press release on August 3, 2026 announcing its second quarter 2026 financial results, including revenue of $76.4 million, a net loss of $3.1 million ($0.28 loss per diluted share), and key operational metrics. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard disclosure mechanism for earnings releases.","company_name":"MEDIFAST INC","ticker":"MED","filing_date":"2026-08-03","form":"8-K","submitted_at":null,"items":[{"id":23661,"accession_number":"0001628280-26-051845","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Medifast issued a press release on August 3, 2026 announcing its second quarter 2026 financial results, including revenue of $76.4 million, a net loss of $3.1 million ($0.28 loss per diluted share), and key operational metrics. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard disclosure mechanism for earnings releases.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T02:31:59.049538+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23661,"accession_number":"0001628280-26-051845","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Medifast issued a press release on August 3, 2026 announcing its second quarter 2026 financial results, including revenue of $76.4 million, a net loss of $3.1 million ($0.28 loss per diluted share), and key operational metrics. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard disclosure mechanism for earnings releases.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-04T02:31:59.049538+00:00","company_name":"MEDIFAST INC","ticker":"MED","filing_date":"2026-08-03"}]}